- Andrew I. Koven Also Joins Neurologix as Company President and Chief Administrative Officer - Read More
from PR Newswire
Neurologix Announces Second Quarter 2011 Financial Results
August 11, 2011
from PR Newswire
Increased Medication "ON" Time and Reduced Medication Complications Reported with Overall Study Summary to Key Government Advisory Agency Read More
from PR Newswire
One-year follow-up data confirm NLX-P101 provides sustained, positive long-term efficacy in Parkinson's disease patients Read More
from PR Newswire
from PR Newswire
Neurologix Announces Year End 2010 Results
March 25, 2011
from PR Newswire
Novel Gene Therapy Agent NLX-P101 Effective in Treating Parkinson's Disease in Phase 2 Trial
March 16, 2011
Lancet Neurology Publishes First Successful Phase 2 Study of Gene Therapy for Parkinson's Disease Patients Read More
from PR Newswire
Neurologix Completes Additional $7 Million Financing
December 06, 2010
from PR Newswire
Neurologix Reports Third Quarter 2010 Financial Results
November 12, 2010
from PR Newswire
Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
October 25, 2010
from PR Newswire
New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
October 01, 2010
from PR Newswire
Neurologix Reports Second Quarter 2010 Financial Results
August 12, 2010
from PR Newswire
from PR Newswire
Neurologix Announces Q1 2010 Financial Results
May 13, 2010
Neurologix Announces Year End 2009 Results
March 26, 2010
Clark Johnson Appointed Neurologix President and CEO
March 10, 2010
Neurologix Appoints Director
February 22, 2010
Neurologix Retains MTS Health Partners, L.P. as Strategic Advisor
February 12, 2010
Neurologix Announces Third Quarter 2009 Financial Results
November 12, 2009
Neurologix to Present at Rodman & Renshaw 11th Annual Healthcare Conference
September 03, 2009
Neurologix Announces Second Quarter 2009 Financial Results
August 12, 2009
Neurologix Announces Q1 2009 Financial Results
May 12, 2009
Neurologix Announces Year End 2008 Results
March 26, 2009
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here